LOWELL, Mass., June 29, 2020 -- Versatope Therapeutics, Inc, a biotechnology company developing vaccines and therapeutics, announced it is expanding its platform to develop a coronavirus vaccine for multiple strains. In addition, the company has progressed on an expanded vacci...

Ehave enters lucrative Market Slated to Grow from $34.28 billion in 2018 $185.66 billion by 2026 MIAMI, FL – June 1, 2020 - Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, annou...

Hesperos Inc., pioneers of the Human-on-a-Chip® in vitro system, today announced the publication of a new peer-reviewed publication that describes how the company’s technology can be used to investigate immune responses following treatment with biological therapeutics for mult...

Dr. Krishna’s main responsibilities will be to assist and advise Ehave on human trials for its cognitive and psychedelic opportunities. MIAMI, FL – June 1, 2020 - Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics delivering evidence-based thera...

San Ramon, CA, May 28, 2020 — Cyberinc, a pioneer in isolation-based cybersecurity solutions, is helping companies address remote work-related security issues with its flagship Isla Isolation Platform, which offers robust protection against ransomware, phishing and other Inter...

A number of UGI customers have received phone calls recently that suggest they are from their utility company and falsely claim they have been overcharged on their energy bills and will receive a rebate and credit on future bills. Customers are then directed to press “1” to cl...

OTTAWA, Ontario, May 28, 2020 – GaN Systems, the global leader in GaN (gallium nitride) power semiconductors, today announced the company has been recognized as a Cool Vendor in the May 2020 Cool Vendors in Technology Innovation Through Power and Energy Electronics report by G...

MIAMI, FL – May 27, 2020 - Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, announced today the Company plans to utilize Telemedicine as part of its platform. Victor S. Dorodny, ...

Edmonton, Alberta, Canada, May 27, 2020 – PACYLEX PHARMACEUTICALS, INC. a pre-IND-stage pharmaceutical company targeting cancers with a new first-in-class therapeutic, announced today that its chief executive officer, Michael Weickert, will participate in the BIO 2020 conferen...

TUCSON, AZ., May 27, 2020 - In June 2019, Aqualung Therapeutics received a three year $1.7M dollar NIH Fastrack Award, for development of a novel immune-based anti-inflammatory therapeutic antibody for critically ill patients with acute lung injury. Due to progress in completi...